Dennis Bourdette

16.6k total citations
251 papers, 9.2k citations indexed

About

Dennis Bourdette is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Dennis Bourdette has authored 251 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pathology and Forensic Medicine, 80 papers in Immunology and 43 papers in Neurology. Recurrent topics in Dennis Bourdette's work include Multiple Sclerosis Research Studies (111 papers), T-cell and B-cell Immunology (42 papers) and Immunotherapy and Immune Responses (41 papers). Dennis Bourdette is often cited by papers focused on Multiple Sclerosis Research Studies (111 papers), T-cell and B-cell Immunology (42 papers) and Immunotherapy and Immune Responses (41 papers). Dennis Bourdette collaborates with scholars based in United States, Slovakia and Australia. Dennis Bourdette's co-authors include Arthur A. Vandenbark, Ruth H. Whitham, Halina Offner, Michelle Cameron, Vijayshree Yadav, Gail Marracci, Rebecca Spain, Lynne Shinto, Michael Forte and Fay B. Horak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Dennis Bourdette

250 papers receiving 8.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dennis Bourdette 3.7k 2.4k 1.6k 1.5k 944 251 9.2k
Hayrettin Tumani 2.4k 0.7× 1.1k 0.4× 2.1k 1.3× 2.9k 1.9× 736 0.8× 226 8.0k
Jacques De Keyser 3.1k 0.8× 978 0.4× 2.3k 1.4× 3.1k 2.1× 1.1k 1.2× 329 12.8k
Alireza Minagar 2.3k 0.6× 1.0k 0.4× 1.8k 1.1× 1.4k 0.9× 403 0.4× 261 7.3k
Andrew Goodman 4.3k 1.2× 611 0.2× 1.3k 0.8× 1.9k 1.2× 830 0.9× 149 7.8k
Sven G. Meuth 3.1k 0.8× 2.7k 1.1× 4.1k 2.5× 2.2k 1.5× 791 0.8× 561 14.0k
Mohammad Ali Sahraian 4.5k 1.2× 810 0.3× 1.1k 0.7× 1.5k 1.0× 637 0.7× 447 7.5k
Kjell‐Morten Myhr 4.3k 1.2× 1.4k 0.6× 1.3k 0.8× 1.2k 0.8× 778 0.8× 211 7.6k
Fredrik Piehl 5.7k 1.6× 2.7k 1.1× 3.7k 2.3× 4.1k 2.7× 817 0.9× 324 15.1k
David Baker 3.6k 1.0× 3.1k 1.3× 4.8k 3.0× 1.5k 1.0× 232 0.2× 296 15.4k
Sandra Amor 3.1k 0.8× 3.9k 1.6× 3.6k 2.2× 1.4k 0.9× 257 0.3× 198 12.4k

Countries citing papers authored by Dennis Bourdette

Since Specialization
Citations

This map shows the geographic impact of Dennis Bourdette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Bourdette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Bourdette more than expected).

Fields of papers citing papers by Dennis Bourdette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Bourdette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Bourdette. The network helps show where Dennis Bourdette may publish in the future.

Co-authorship network of co-authors of Dennis Bourdette

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Bourdette. A scholar is included among the top collaborators of Dennis Bourdette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Bourdette. Dennis Bourdette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartung, Daniel M., Sheila Markwardt, & Dennis Bourdette. (2025). Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program. Neurology Clinical Practice. 15(1). e200424–e200424. 1 indexed citations
2.
Hartung, Daniel M., Kirbee Johnston, Jessina C. McGregor, & Dennis Bourdette. (2022). Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population. International Journal of MS Care. 24(2). 90–97. 5 indexed citations
3.
Hartung, Daniel M., Kirbee Johnston, Jessina C. McGregor, & Dennis Bourdette. (2021). Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program. Neurology Clinical Practice. 12(1). 36–42. 2 indexed citations
4.
Simkins, Tyrell, Greg J. Duncan, & Dennis Bourdette. (2021). Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications. Current Neurology and Neuroscience Reports. 21(6). 26–26. 40 indexed citations
5.
Hartung, Daniel M., Kirbee Johnston, Jessina C. McGregor, & Dennis Bourdette. (2020). The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102554–102554. 5 indexed citations
6.
Hartung, Daniel M., Kirbee Johnston, Dennis Bourdette, Randi Chen, & Chien‐Wen Tseng. (2020). Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs. Neurology Clinical Practice. 11(4). 298–303. 7 indexed citations
7.
Silbermann, Elizabeth, Angela Senders, Michelle Cameron, et al.. (2020). Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update. Multiple Sclerosis and Related Disorders. 41. 102041–102041. 14 indexed citations
8.
Falardeau, Julie, Gail Marracci, Michele Mass, et al.. (2019). Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(2). 2454270161–2454270161. 10 indexed citations
9.
Dale, Marian L., et al.. (2017). Inflammatory pathology and rapidly progressive dementia contribute to the classic PSP phenotype (P4.014). Neurology. 88(16_supplement). 1 indexed citations
10.
Yadav, Vijayshree, Michele Mass, Gail Marracci, et al.. (2017). Oral lipoic acid as a treatment for acute optic neuritis: A blinded, placebo-controlled randomized trial (P6.388). Neurology. 88(16_supplement). 1 indexed citations
11.
Mazumder, Rajarshi, William E. Lambert, Thuan Nguyen, Dennis Bourdette, & Michelle Cameron. (2015). Fear of Falling Is Associated with Recurrent Falls in People with Multiple Sclerosis. International Journal of MS Care. 17(4). 164–170. 58 indexed citations
12.
Senders, Angela, Douglas Hanes, Dennis Bourdette, Ruth H. Whitham, & Lynne Shinto. (2014). Improving the Patient-Reported Outcome Experience for Participants and PI's: Feasibility and Validity of PROMIS. The Journal of Alternative and Complementary Medicine. 20(5). A13–A13. 1 indexed citations
13.
Yadav, Vijayshree, Gail Marracci, Edward Kim, et al.. (2014). Effects of a Low Fat Plant Based Diet in Multiple Sclerosis (MS): Results of a 1- Year Long Randomized Controlled (RC) Study (P6.152). Neurology. 82(10_supplement). 4 indexed citations
14.
Lovera, Jesús, Edward Kim, Mary Anne Fitzpatrick, et al.. (2012). Ginkgo biloba does not improve cognitive function in MS. Neurology. 79(12). 1278–1284. 40 indexed citations
15.
Shinto, Lynne, Carlo Calabrese, Cynthia D. Morris, et al.. (2008). A Randomized Pilot Study of Naturopathic Medicine in Multiple Sclerosis. The Journal of Alternative and Complementary Medicine. 14(5). 489–496. 25 indexed citations
16.
Forte, Michael, Bruce G. Gold, Gail Marracci, et al.. (2007). Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proceedings of the National Academy of Sciences. 104(18). 7558–7563. 182 indexed citations
17.
Shinto, Lynne, et al.. (2004). Complementary and Alternative Medicine in Multiple Sclerosis: Survey of Licensed Naturopaths. The Journal of Alternative and Complementary Medicine. 10(5). 891–897. 22 indexed citations
18.
Vandenbark, Arthur A., Y. K. Chou, Dennis Bourdette, Ruth H. Whitham, & Halina Offner. (1997). Therapeutic application of T cell receptor peptides. Drug News & Perspectives. 10(6). 341–346. 7 indexed citations
19.
Vandenbark, Arthur A., Y. K. Chou, Ruth H. Whitham, et al.. (1996). TCR peptide vaccination induced TH2 immune regulation in multiple sclerosis. The FASEB Journal. 10(6). 1 indexed citations
20.
Chou, Yuan K., Richard E. Jones, Dennis Bourdette, et al.. (1994). Human myelin basic protein (MBP) epitopes recognized by mouse MBP-selected T cell lines from multiple sclerosis patients. Journal of Neuroimmunology. 49(1-2). 45–50. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hayrettin Tumani Breakdown of academic impact, for papers by Jacques De Keyser Breakdown of academic impact, for papers by Alireza Minagar Breakdown of academic impact, for papers by Andrew Goodman Breakdown of academic impact, for papers by Sven G. Meuth Breakdown of academic impact, for papers by Mohammad Ali Sahraian Breakdown of academic impact, for papers by Kjell‐Morten Myhr Breakdown of academic impact, for papers by Fredrik Piehl Breakdown of academic impact, for papers by David Baker Breakdown of academic impact, for papers by Sandra Amor
Rankless by CCL
2026